Melanoma Technical References
558. |
NEW! |
THE MATTEK STORY — HOW THE THREE Rs PRINCIPLES LED TO 3-D TISSUE SUCCESS!
Sheasgreen, J., Klausner, M., Kandárová, H., and Ingalls, D.
MatTek Corporation, Ashland, MA, USA.
ATLA, 37, 611–622, (2009).
|
525. |
NEW! |
UPREGULATION OF SOX9 INHIBITS THE GROWTH OF HUMAN AND MOUSE MELANOMAS AND RESTORES THEIR SENSITIVITY TO RETINOIC ACID.
Passeron, T., Valencia, J.C., Namiki, T., Vieira, W.D., Passeron, H., Miyamura, Y., and Hearing, V.J.
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland, USA.
J. Clin. Invest., 119, 954-963 (2009)
|
498. |
NEW! |
A SMALL-MOLECULE E2F INHIBITOR BLOCKS GROWTH IN A MELANOMA CULTURE MODEL.
Ma1, Y., Kurtyka1, C.A., Boyapalle1, S., Sung2, S-S. Lawrence2, H., Guida2, W., and Cress1, W.D.
1Molecular Oncology Program and 2High Throughput Screening and Chemistry Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Cancer Res., 68 (15):6292–9 (2008).
|
455. |
|
ROSCOVITINE INHIBITS DIFFERENTIATION AND INVASION IN A THREE-DIMENSIONAL SKIN RECONSTRUCTION MODEL OF METASTATIC MELANOMA.
Mohapatra1, S., Coppola1, D., Riker2, A.I., and Pledger1, W.J.
1Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida, 2University of South Alabama-Mitchell Cancer Institute, Mobile, Alabama.
Mol Cancer Res; 5, (2), 145–51, (2007).
|
365. |
|
RECONSTRUCTED HUMAN SKIN MODEL TO STUDY MELANOMA AT DIFFERENT STAGES OF PROGRESSION.
Kaluzhny, Y., Sur, G., Klausner, M.
MatTek Corporation, Ashland, MA, United States.
Presented at Society of Investigative Dermatology, St.Louis, MO, May 4-7, (2005).
|
326. |
|
HUMAN MELANOMA DEVELOPMENT IN RECONSTRUCTED SKIN MODELS.
Kubilus, J., Neal, P., Kaluzhny, Y., Sur, G., and Klausner, M.
MatTek Corporation, Ashland, MA.
J. Invest. Dermatol., 122, (3), A158, Abstract #945, (2004).
|
100. |
|
ABSTRACT PAK
In order to facilitate the literature review process, the Abstract Pak contains the abstract portions of the listed posters and publications.
|
|
|
